AGREEMENT AND GENERAL RELEASEAgreement and General Release • February 22nd, 2019 • Momenta Pharmaceuticals Inc • Biological products, (no disgnostic substances) • Massachusetts
Contract Type FiledFebruary 22nd, 2019 Company Industry JurisdictionThis Agreement and General Release (hereinafter “Agreement” or “Agreement and General Release”) is made by and between Momenta Pharmaceuticals, Inc. (“Momenta” or the “Company”) and Bruce Leicher (“Employee”). In order to resolve all matters relating to Employee’s employment, including but not limited to issues relating to the cessation of Employee’s employment, Momenta and Employee (collectively referred to as “the Parties”), voluntarily agree that:
EMPLOYMENT AGREEMENTEmployment Agreement • February 22nd, 2019 • Momenta Pharmaceuticals Inc • Biological products, (no disgnostic substances) • Massachusetts
Contract Type FiledFebruary 22nd, 2019 Company Industry JurisdictionTHIS EMPLOYMENT AGREEMENT (the "Agreement"), made this 10th day of August, 2017, is entered into by Momenta Pharmaceuticals, Inc., a Delaware corporation with its principal place of business at 675 West Kendall Street, Cambridge, Massachusetts (the "Company"), and Alejandra Carvajal, an individual residing at 12 Wyman Street Waban, MA 02468 (the "Employee").
AGREEMENT AND GENERAL RELEASEGeneral Release Agreement • February 22nd, 2019 • Momenta Pharmaceuticals Inc • Biological products, (no disgnostic substances) • Massachusetts
Contract Type FiledFebruary 22nd, 2019 Company Industry JurisdictionThis Agreement and General Release (hereinafter “Agreement” or “Agreement and General Release”) is made by and between Momenta Pharmaceuticals, Inc. (“Momenta” or the “Company”) and Scott Storer (“Employee”). In order to resolve all matters relating to Employee’s employment, including but not limited to issues relating to the cessation of Employee’s employment, Momenta and Employee (collectively referred to as “the Parties”), voluntarily agree that:
FIFTH AMENDMENT TO LEASELease • February 22nd, 2019 • Momenta Pharmaceuticals Inc • Biological products, (no disgnostic substances)
Contract Type FiledFebruary 22nd, 2019 Company IndustryTHIS FIFTH AMENDMENT TO LEASE (this "Amendment”) is entered into as of this 24th day of April, 2018 (the "Amendment Execution Date"), by and between BMR-ROGERS STREET LLC, a Delaware limited liability company ("Landlord "), and MOM ENTA PHARMACEU TICALS, INC., a Delaware corporation ("Tenant").